<DOC>
	<DOCNO>NCT00140556</DOCNO>
	<brief_summary>Radiotherapy ( RT ) concurrent chemotherapy represent state art curative intent treatment locally advance squamous carcinoma head neck . Tumor hypoxia high level angiogenesis ( blood vessel formation ) associate treatment failure . Preclinical model reveal radiotherapy may induce tumor secretion vascular endothelial growth factor ( VEGF ) . Curability may consequently reduce multiple mechanism . Over-expression epidermal growth factor receptor ( EGFR ) also occur commonly increase risk treatment failure . The addition EGFR blockade RT alone increase chance cure . Concurrent VEGF EGFR blockade could synergistic one another improve effectiveness concurrent chemoradiation advance head neck cancer . This study add angiogenic epidermal growth factor receptor ( EGFR ) blockade establish program curative intent concurrent chemoradiation locally advanced head neck cancer . The safety effectiveness deliver drug bevacizumab Tarceva conjunction twice daily irradiation concurrent cisplatin ( CDDP ) chemotherapy determine .</brief_summary>
	<brief_title>Angiogenic EGFR Blockade With Curative Chemoradiation Advanced Head Neck Cancer</brief_title>
	<detailed_description>Pre Radiation Period : - Bevacizumab ( 10 mg/kg ) day -14 0 , - Tarceva ( 100 mg ) daily -14-0 , - Bevacizumab ( 10 mg/kg ) day -14 0 ; Tarceva ( 100 mg ) daily -14-0 Chemoradiation Period : - Radiotherapy may deliver via conventional 2-D , conformal 3-D , intensity modulate ( IMRT ) technique clinically indicate . Radiotherapy CDDP dose deliver uniformly treatment cohort : - RT : 1.25 Gy BID M-F 6 hour interfraction interval - Treatment break week 4 . Total dose 70 Gy/7 week - CDDP : 33 mg/m2 M-W week 1 5 RT standard DUMC hydration anti-emetic regimen - Bevacizumab ( 10mg/kg ) : Monday week 1 , 3 , 5 , 7 RT - Tarceva ( 100 mg ) : Daily week 1-7 treatment , except day receive CDDP Safety Assessments : - Baseline weekly assessment blood pressure urine protein : creatinine ratio lead chemoRT phase treatment - Baseline carotid Doppler ultrasound evaluation - Carotid Doppler ultrasound evaluation 1 month post-chemoRT Efficacy Assessments : - MR Imaging/Spectroscopy do baseline , end lead-in phase , end week 1 chemoRT , end chemoRT - Angiogenic EGFR related cytokine . Specifically , blood sample obtain assay level VEGF , b-FGF , IL-8 , D-dimer , EGF , TGF . These sample obtain date MR study additional set sample obtain midpoint lead phase treatment ( day -7 ) . Clinical Assessments : - All patient undergo minimum weekly interval history physical examination include fiberoptic pharyngoscopy/laryngoscopy indicate Department Radiation Oncology monitor side effect response treatment per standard routine care patient head neck cancer . - Patient compliance Tarceva administration monitor via diary MRI/MRS ( Magnetic Resonance Spectroscopy ) DE-MRI</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Pharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Locally advanced squamous carcinoma head neck ( AJCC stag II/IV , M0 , exclude T1N1 T1N2 ) undergo curative intent concurrent chemoradiation . Previous treatment sort biopsy allow . Eligible anatomic site : oral cavity oropharynx hypopharynx supraglottic glottic larynx KPS &gt; 60 Nasopharynx primary History malignancy basal cell skin cancer . History claudication , bleeding , thromboembolic disorder . Patients receive heparin Coumadin therapy ineligible . Primary tumor lymph node encasement carotid artery Blood pressure &gt; 150/100 mmHg Unstable angina New York Heart Association ( NYHA ) Grade II great congestive heart failure History myocardial infarction within 6 month History stroke within 6 month Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior Day 0 ; anticipation need major surgical procedure course study . Minor surgical procedure , fine needle aspiration , core biopsy within 7 day prior Day 0 Pregnant ( positive pregnancy test ) lactate Urine protein : creatinine ratio â‰¥ 1.0 screen History abdominal fistula , gastrointestinal perforation , intraabdominal abscess within 6 month prior Day 0 Serious , nonhealing wound , ulcer , bone fracture AST , ALT , bilirubin &gt; 1.5 x normal PT PTT &gt; 1.5 x normal Platelets &lt; 100,000 WBC &lt; 2000 Hgb &lt; 10 Creatinine clearance &lt; 60 mL/hr Refusal provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>head neck cancer</keyword>
	<keyword>target therapy</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>erlotinib</keyword>
	<keyword>Tarceva</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>concurrent chemotherapy</keyword>
	<keyword>pharynx cancer</keyword>
	<keyword>tonsil cancer</keyword>
	<keyword>hyperfractionation</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>epidermal growth factor</keyword>
	<keyword>vascular endothelial growth factor</keyword>
	<keyword>magnetic resonance spectroscopy</keyword>
	<keyword>cancer head neck</keyword>
	<keyword>upper aerodigestive tract neoplasm</keyword>
	<keyword>pharynx neoplasm</keyword>
</DOC>